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ROLE OF UROFLOWMETRY IN A CLINICAL STUDY 
OF PATIENTS WITH CHRONIC PROSTATITIS
Tatyana Kvyatkovskaya, 
Doctor of Medical Sciences, Professor, 
SE “Dnepropetrovsk Medical Academy of the Ministry of Health of Ukraine”,
Yevgeniy Kvyatkovsky, 
Candidate of Medical Sciences, 
Clinical hospital N9 of the Dnipro city,
Valentin Kosse, MD, Professor,
Dnipro Medical Institute of Traditional and Non Traditional Medicine
Annotation. We studied 154 patients with chronic prostatitis aged 20-70 years (mean 
age 48.9 years). The control group consisted of 66 patients aged 20-70 years (mean age 48.7 
years) without urinary tract pathology. All patients underwent uroflowmetry using a Potok-K 
uroflowmeter and an ultrasound examination of the bladder and prostate with determination of 
post-void residual volume and prostate volume. During uroflowmetry, the average volumetric 
urine flow rate, maximum volumetric urine flow rate, urine flow acceleration, flow time, time 
to maximum flow and voiding waiting time were determined, and nomograms of the maximum 
and average volumetric flow rate were used and a qualitative assessment of uroflowgrams was 
performed. A normal type of uroflogram was detected in 42.9% of patients with chronic prostatitis, 
intermittent in 12.3%, superflow in 9.1%, preobstructive in 9.1%, obstructive in 13.6%, and 
interrupted in 13% patients. 
For patients of a younger age, intermittent and superflow types of uroflograms are 
characteristic, which may indicate detrusor sphincter dysinergy and hyperactivity of the bladder. 
In older patients, obstructive and obstructively interrupted uroflowgram types are more often 
observed. In patients with chronic prostatitis, the earliest indicator of urodynamic disturbance is 
a decrease in urine flow acceleration. Marked changes in uroflowgrams were noted in 26.6% of 
patients with obstructive and obstructively interrupted type of voiding. These patients are shown 
the appointment of alpha-1-blockers that improve the function of the detrusor and the neck of 
the bladder. The proposed pharmacurodynamic test with a single dose of silodosin allows you to 
develop indications for the appointment of alpha-1-blockers.
Key words: uroflowmetry, chronic prostatitis, urodynamics of the lower urinary tract.
Chronic prostatitis is one of the most common urological diseases, often accompanied 
by the manifestation of dysuric symptoms, pain in the genitourinary system and is often 
associated with sexual dysfunction [1]. The frequency of chronic prostatitis among the 
male population is 5-8%, among men 20-50 years old – up to 10%, older than 50 years old 
– 9-16% [2-4], in Ukraine among men 20-60 years old – about 19% [ 5]. Approximately 
50-60% of men with chronic prostatitis experience lower urinary tract symptoms [6].
An impressive layer of publications on the diagnosis and treatment of chronic 
prostatitis, unfortunately, contains few works on the urodynamics of the lower urinary 
tract. An objective assessment of urodynamic disorders in chronic prostatitis is an 
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important factor in the development of therapeutic tactics. At the same time, the need 
to use uroflowmetry as a non-invasive method for assessing urodynamics of the lower 
urinary tract with prostatitis has not yet been sufficiently argued.
The purpose of the study was to clarify the significance of uroflowmetry data in the 
examination of patients with chronic prostatitis.
Materials and methods. 154 patients with chronic prostatitis type III A (19 patients) 
and III B (135 patients) aged 20 to 70 years (mean age 48.9 years) were studied. Disease 
duration varied from 1 year to 6 years. The control group consisted of 66 patients 
without pathology of the urinary tract, aged from 21 years to 70 years with an average 
age of 48.7 years similar to the age of patients with chronic prostatitis. All patients 
underwent examination, including digital rectal examination, microscopy of prostate 
secretion, urethral scraping by PCR, bacteriological examination of prostate and urine 
secretion, urinalysis, ultrasound with determination of post-void residual volume (PVR) 
and prostate volume (PV), as well as uroflowmetry.
Studies of urine flow during urination were performed using a Flow-K uroflowmeter 
(Ukraine, developer A.E. Kvyatkovsky). Uroflowmetry results were evaluated by the 
following parameters: voided volume (ml), average volumetric urine flow rate Qav (normal 
10-20 ml/s), maximum volumetric urine flow rate Qmax (normal 15-30 ml / s), urine flow 
acceleration UFA (about 5 ml/s²), flow time TQ (normal <20 s), time to maximum flow 
Tmax (normal 4-12 s), voiding waiting time Twait (normal 1-5 s) [7]. Using the Liverpool 
Nomograms, the average and maximum volumetric flow rates corresponded automatically 
to the age norm regardless of the volume of urine excreted. Considering that the graphical 
type of curves is of no small importance in the interpretation of uroflograms, a qualitative 
assessment of uroflograms was carried out.
Studies of the prostate gland, bladder, determination of prostate volume and 
PVR were performed using a HONDA HS-2000 ultrasound machine. Statistical data 
processing was carried out in Excel; Student's test was used to compare statistical data.
Results and discussions. As a result of the analysis of the obtained uroflograms in 
patients with chronic prostatitis, the following types of curves were distinguished: “normal”, 
“superflow type” uroflograms (with high flow rate, rapid achievement of the maximum flow 
rate and flow time), “intermittent type” uroflograms (with alternating significant increase 
and decrease in flow rate), "obstructive type" uroflograms (with a significant decrease in 
flow rate parameters, values of speed indicators for nomogram below the line of the 25% 
distribution of normal indicators), uroflowgrams of the “preobstructive type” (with a slight 
decrease in velocity indicators and a slight deviation from the norm on the nomograms), 
“uroflowgrams of the obstructively interrupted type” (with a significant decrease in the 
velocity of urine flow and interruption of voiding) (tab. 1).
In chronic prostatitis, the normal type of uroflowgrams reflecting normal urination 
was found in 42.9% of cases, deviations from the norm were observed more often - in 
57.1% of cases.
Of the uroflowgrams with deviations from the norm, uroflowgrams with signs 
of dynamic infravesical obstruction of various degrees of severity (preobstructive, 
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obstructive, obstructively interrupted type) were most often found – more than a 
third of uroflowgrams (35.7%). Of all cases with a deviation from the normal type of 
uroflowgram, they amounted to 62.5%.
Table 1
Frequency of various types of uroflowgrams in patients with chronic prostatitis
Types of uroflowgrams Number of patients Frequency The average age of patients (age limits), years
Normal 66 42,9 % 42,8 (20-70)
Superflow 14 9,1 % 31,2 (22-55)
Intermittent 19 12,3 % 46,9 (27-70)
Preobstructive 14 9,1 % 52,5 (27-70)
Obstructive 21 13,6 % 54,3 (30-70)
Obstructively 
interrupted 20 13 % 57,4 (25-70)
In a quarter of cases (25.3%), uroflowgrams with an unstable flow and sharp 
fluctuations in the volumetric flow rate (intermittent and obstructively interrupted types) 
were observed, which of all cases with deviations from the norm was 44.3%. The irregular 
nature of intermittent uroflowgrams is inherent in disorders such as detrusor sphincter 
dysinergy and dysfunction of the bladder neck. With the obstructively interrupted type of 
uroflowgram, apparently, there is a combination of mismatch between the detrusor and 
the sphincter apparatus of the urethra, as well as dynamic infravesical obstruction due to 
inflammation and venous stasis in the prostate.
Rarely, there was a rapid type of uroflowgram (9.1%), moreover, in patients of a 
younger age, which reflects their tendency to hyperactivity of the bladder.
The data on the prostate volume and PVR obtained as a result of ultrasound 
examination of patients with chronic prostatitis are presented in table. 2.
Table 2
Voided volume, prostate volume and PVR in patients with 
chronic prostatitis, M ± m
Types of uroflowgrams Voided volume (ml) Prostate volume (cm3) PVR (ml)
Normal 235,5±10,3 16,95±0,68 8,79±0,88
Superflow 221,6±21,8 15,53±1,55 8,14±1,49
Intermittent 252,3±18,2 16,42±1,13 9,64±1,36
Preobstructive 212,6±23,8 18,59±1,58 15,96±2,87
Obstructive 243±20,1 17,57±1,02 29,02±4,82
Obstructively 
interrupted 207,9±22,5 21,20±1,26 27,30±7,48
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The average values of prostate volume and PVR in patients of the first four types 
of uroflowgrams were within normal limits. In patients with chronic prostatitis with 
obstructive urination, the average prostate volume did not statistically differ from that 
in patients with a normal type uroflowgram, but PVR was 3 times large on average (p 
<0.01). We conditionally divided this group of patients with chronic prostatitis into two 
subgroups: patients with PVR ≤ 30 ml and patients with PVR > 30 ml. It turned out that 
in patients with PVR > 30 ml the average prostate volume was 1.35 times greater (p 
<0.01), and the average PVR was 3.88 times greater (p <0.001) compared with the first 
subgroup. A slight increase in prostate volume in the second subgroup is explained by 
swelling of the prostate gland, flattening of the median groove, which was detected by 
palpation. The average age of patients in the first subgroup was 51.9 years, the second 
– 58.1 years. An increase in PVR in the second subgroup can be associated both with 
stagnation in the prostate gland and with an age-related decrease in the compensatory 
capabilities of the detrusor.
Uroflowmetric indicators of patients in the control group, as well as patients with 
chronic prostatitis, depending on the type of uroflowgram are presented in table. 3.
Table 3
Uroflowmetric indicators of urine flow in the control group and 
patients with chronic prostatitis, M ± m
Types of 
uroflowgrams
Qav 
(ml/s)
Qmax   
(ml/s)
UFA 
(ml/s2)
TQ 
(s)
Tmaх 
(s)
Twait 
(s)
Normal 
(control 
group)
17,47±0,67 30,24±1,08 4,97±0,40 14,45±0,49 7,43±0,37 4,90±0,48
All types of 
uroflowgrams 
(prostatitis)
12,49±0,53 22,55±0,85 3,02±0,22 23,84±1,27 11,81±0,70 9,95±1,74
Normal 14,66±0,53 25,17±0,91 3,37±0,21 17,00±0,94 8,83±0,67 5,22±0,70
Superflow 11,36±0,84 23,89±2,10 2,04±0,20 23,43±1,91 13,02±1,15 12,55±2,83
Intermittent 25,88±1,14 41,25±1,83 8,68±0,64 8,45±0,62 5,12±0,47 10,17±2,59
Preobstructive 8,41±0,57 16,21±1,92 1,93±0,54 24,67±1,48 10,6±1,13 13,58±8,95
Obstructive 5,47±0,44 12,30±0,99 1,36±0,35 48,67±4,57 17,22±2,89 6,84±1,88
Obstructively 
interrupted 7,25±0,74 14,70±1,55 1,36±0,54 30,95±2,95 20,35±2,40 22,11±10,07
If we do not differentiate the results of uroflowmetry in chronic prostatitis depending on 
the types of uroflowgrams, then all quantitative indicators, with the exception of the urine 
flow acceleration, which was reduced, on average corresponded to the generally accepted 
norm. At the same time, in comparison with the control group, the indicators of the volumetric 
flow rate were lower, and the time indicators were higher. The urine flow acceleration was 
reduced by 1.6 times compared with the control group, Qmax – by 1.3 times.
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In the group of patients with chronic prostatitis with a normal type of uroflowgram, 
the average quantitative values of the uroflowmetry parameters did not go beyond the 
generally accepted norm, and on the Qmax and Qav nomograms exceeded the 50th 
percentile. The only indicator whose average value was lower was UFA. However, 
when comparing the uroflowmetry parameters of this group of patients with chronic 
prostatitis with a control group of men, similar in quantitative, age composition and 
average voided volume, all speed indicators were significantly lower (p <0.05). The flow 
time was significantly greater (p <0.05) than in the control group, Tmax and Twait did 
not differ significantly (p> 0.05).
In patients with chronic prostatitis with intermittent type of uroflogram, the flow 
rate of urine during urination underwent significant fluctuations, and uroflograms 
were intermittent. These manifestations are associated with the alternation of episodes 
of uncontrolled contraction and relaxation of the urethral sphincter during urination. 
The frequency and amplitude of the fluctuations in the volumetric flow rate had a wide 
spectrum of patterns – from slow-wave to “staccato”. The urine flow acceleration in 
these patients on average was significantly lower compared with the group of patients 
with the normal type of curve (p <0.01), other indicators of velocity were within normal 
limits, although slightly reduced compared with the control group. Flow time increased 
by more than 2 times (p <0.01). At the same time, the average values of TQ and Tmax 
only slightly exceeded the indicators of the generally accepted norm.
Patients with a superflow type of uroflogram had a significant increase in urine 
flow rate, especially UFA, and a decrease in TQ and Tmax relative to the control group 
and the group of patients with a normal curve type (p <0.05), which indicated detrusor 
hyperactivity. It is necessary to pay attention to the fact that the average age of patients in 
this group was less than in other groups, and averaged 31.2 ± 2.5 years. In patients with 
a superflow and frequent urination, a mirabegron beta-3-adrenergic agonist, which has a 
relaxing effect on the detrusor, can have a good effect.
In the group of patients in which uroflograms corresponded to unexpressed 
obstruction, Qmax and Qav were on average slightly lower than the generally accepted 
norm and significantly lower than in the control group (p <0.01), the rate of urine flow 
acceleration was most reduced (on average 2.6 times). Often the dome of the curve was 
shifted to the right, which may indicate a slow opening of the neck of the bladder. TQ 
and Tmax were increased. Increased by 2.8 times was the voiding waiting time.
Thus, unexpressed changes in the flow of urine in chronic prostatitis in young 
people were more often manifested by an intermittent and superflow type of urination, 
in men older than 50 years – the appearance of signs of preobstructive type, which may 
be associated with age-related changes in the genitourinary system.
In the group of patients with obstructive urination, urine flow rates with uroflowmetry 
were reduced by 2 or more times, especially UFA (2.5 times on average), and TQ and Tmax 
were increased compared to the group with the normal type of uroflowgram (p <0,01).
In patients with chronic prostatitis with an obstructively interrupted type of 
uroflowgram, uroflowmetry indicators were almost at the same level as in the group 
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of patients with obstructive type of uroflowgram. There was a significant decrease in 
all velocity indicators and an increase in all time indicators compared with the group 
of patients with the normal type of uroflowgram (p <0.05), regardless of the number 
of PVR. The indicators of uroflowmetry in the subgroup of patients with PVR > 30 ml 
did not differ significantly from the subgroup of patients with PVR ≤ 30 ml, with the 
exception of UFA, which was significantly lower by 1.79 times, and Twait, which was the 
largest among all groups of patients (41.71 ± 24.76 s). An increase in the voiding waiting 
time in patients with chronic prostatitis may be associated with difficulty opening the 
neck of the bladder due to dynamic infravesical obstruction. An obstructively interrupted 
uroflowgram type was more often detected in patients with chronic prostatitis older than 
50 years old, and was observed both in patients with an increased amount of residual 
urine and in patients with a small amount of residual urine. The quantitative parameters 
of uroflowmetry were independent of PVR, and PVR was not associated with PV.
The use of alpha-blockers for the treatment of patients with chronic prostatitis, 
along with the appointment of antibacterial, non-steroidal anti-inflammatory and 
other drugs, can significantly improve urination [8, 9]. Alpha-adrenergic blockers, in 
addition to affecting the smooth muscles of the prostate and the internal sphincter of 
the urethra, being vasoactive substances, improve hemomicrocirculation in the prostate 
gland, impaired in chronic prostatitis. Their use is most relevant for the treatment of 
patients with obstructive and obstructively interrupted uroflowgram type. However, it 
can also be used to treat patients with manifestations of detrusor-sphincter dysinergy: 
with an obstructively intermittent and intermittent type of uroflowgram. The solution 
to the question of the appropriateness of the appointment of alpha-1-blockers is 
greatly simplified, thanks to the pharmacurodynamic test with silodosin, proposed 
by A.E. Kvyatkovsky [10]. Pharmacourodynamic test consists in uroflowmetry with 
determination of the maximum and average volumetric urine flow rate before taking 
and 2.5-3 hours after taking 8 mg of silodosin. Given the increase in the maximum and 
average volumetric urine flow rate by 25-30%, drug therapy with silodosin is prescribed, 
in the absence of changes or a slight increase in the maximum and average volumetric 
urine flow rate, treatment with alpha-1-blocker is considered inappropriate. In this case, 
further examination is necessary in order to identify the organic cause of obstruction. 
Pharmacourodynamic test is a highly informative method for predicting the expected 
result of treatment with silodosin. According to our, together with a team of authors, 
data [7], the use of alpha-1-adrenergic blocking agents in the complex treatment of 
chronic bacterial prostatitis gives good results: an improvement in lower urinary tract 
urodynamics was noted in 96% of patients.
Conclusions. Considering that more than half of patients with chronic prostatitis 
of type III A and III B have urination disorders (57.1%), uroflowmetry is important for 
their objectification.
The normal type of uroflowgram was detected in 42.9% of patients with chronic 
prostatitis. Unexpressed changes in the parameters of uroflowgrams (in patients with 
intermittent, superflow and preobstructive type of uroflowgrams) were detected in 
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30.5% of patients, pronounced changes in the parameters and nature of uroflowgrams 
(in patients with obstructive and obstructively interrupted type of uroflowgrams) – in 
26.6% of patients.
Intermittent and rapid types of uroflowgrams, indicating detrusor sphincter dysinergy 
and hyperactivity of the bladder, are more often observed in patients of a younger 
age, obstructive and obstructively interrupted types, reflecting dynamic infravesical 
obstruction, in older patients.
The importance of the urine flow acceleration indicator for the early detection of 
urodynamic disorders in patients with chronic prostatitis is indicated by its primary 
decrease in patients with uroflowgram type, identified by other indicators and nomograms 
as normal, as well as its significant decrease in patients with preobstructive urination.
Quantitative indicators of uroflowmetry in chronic prostatitis are not directly 
dependent on the prostate volume and the post-void residual volume.
Patients with obstructive and obstructively interrupted uroflowgrams, which make 
up about a quarter of all patients with chronic prostatitis, are indicated for the use of 
alpha-1-blockers. The proposed pharmacurodynamic test with a single dose of silodosin 
allows you to develop indications for the appointment of alpha-1-blockers.
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